C12N 2770/24151
Methods of production or purification of viral material
C12N2770/24151 (Methods of production or purification of viral material) appears on 104 US grants and 147 published applications in this corpus.
Search patents in C12N- Granted patents
- 104
- Published applications
- 147
- Assignees
- 98
- Inventors
- 314
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 2 |
| 2006 | 0 | 3 |
| 2007 | 1 | 1 |
| 2008 | 0 | 5 |
| 2009 | 3 | 4 |
| 2010 | 0 | 5 |
| 2011 | 4 | 1 |
| 2012 | 2 | 4 |
| 2013 | 2 | 2 |
| 2014 | 5 | 7 |
| 2015 | 2 | 8 |
| 2016 | 3 | 3 |
| 2017 | 2 | 8 |
| 2018 | 6 | 18 |
| 2019 | 9 | 11 |
| 2020 | 11 | 16 |
| 2021 | 12 | 12 |
| 2022 | 13 | 5 |
| 2023 | 4 | 7 |
| 2024 | 9 | 12 |
| 2025 | 3 | 9 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Vero cell line that can be suspension-cultured in serum-free medium, preparation method therefor, and method for preparing viruses for vaccines by using novel cell line28 Oct 2025US 12,454,680 B2SK Bioscience Co., Ltd.
- Virus purification and formulation process20 May 2025US 12,305,198 B2Global Life Sciences Solutions USA LLC
- Virus purification4 Feb 2025US 12,214,033 B2Valneva SE
- Zika vaccines and immunogenic compositions, and methods of using the same8 Oct 2024US 12,109,260 B2Takeda Vaccines, Inc.
- Zika virus vaccine1 Oct 2024US 12,102,673 B2Valneva Austria GmbH
- Systems and Methods for Delivery of Viral Antigens8 Oct 2026US 2026/0306610 A1Veergen Inc.
- Dengue vaccine3 Sep 2026US 2026/0256903 A1VLP Therapeutics, LLC
- Dengue vaccine formulation28 May 2026US 2026/0144859 A1Takeda Vaccines, Inc.
- Compositions and methods of vaccination against dengue virus in children and young adults24 Jul 2025US 2025/0235522 A1Takeda Vaccines, Inc.
- Compositions comprising modified flavivirus e glycoproteins and methods of making and using the same12 Jun 2025US 2025/0188130 A1The University of North Carolina at Chapel Hill
Most cited
By later US patents
- Production of orthomyxoviruses in monkey kidney cells using protein-free media88US 6,146,873 ABaxter Aktiengesellschaft · 2000
- Stabilizing agents for live viruses for preparing vaccines, and stabilized vaccines containing said stabilizing agents56US 4,500,512 AInstitut Pasteur · 1985
- Attenuated Japanese encephalitis virus adapted to Vero cell and a Japanese encephalitis vaccine27US 6,309,650 B1Cheil Jedang Corporation · 2001
- Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms23US 6,197,568 B1The Regents of the University of Michigan · 2001
- Flavivirus reporter virus and methods of making and using the same21US 8,691,961 B1Integral Molecular, Inc. · 2014